As of June 30, 2026, QingSong Health Corporation carries a market capitalization of 2.48B, placing it among publicly traded companies globally. Its enterprise value stands at 1.61B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 2.48B |
| Enterprise Value | 1.61B |
As of June 30, 2026, QingSong Health Corporation has 204.33M shares outstanding.
| Shares Outstanding | 204.33M |
These figures are as of June 30, 2026.
| PB Ratio | 2.35 |
| P/TBV Ratio | 2.40 |
As of June 30, 2026, QingSong Health Corporation maintains a current ratio of 6.89, meaning it holds 6.9x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 6.89 |
| Quick Ratio | 4.94 |
| Debt / Equity | 0.27 |
These figures cover the twelve months ended June 30, 2026.
| Employee Count | 213.00 |
These figures are as of the close on October 23, 2026. The 50-day moving average sits at 4.34, while the 200-day moving average is 48.32.
| 50-Day Moving Average | 4.34 |
| 200-Day Moving Average | 48.32 |
As of June 30, 2026, QingSong Health Corporation holds 864.42M in cash and equivalents against 2.83M in total debt, resulting in a net debt position of -586.65M. Total book value stands at 1.06B, with working capital of 1.03B providing operational flexibility.
| Cash & Cash Equivalents | 864.42M |
| Total Debt | 2.83M |
| Net Debt | -586.65M |
| Equity (Book Value) | 1.06B |
| Book Value Per Share | 5.17 |
| Working Capital | 1.03B |
Already premium?